HCVC3 min read
Exclusive: Orakl Oncology raises $34m to test cancer drugs on ‘virtual patients’
Swedish investor Norrsken and Paris-based VC Singular co-led the round
By Daphné Leprince-RinguetSifted AI

Read the full story
Originally published by Sifted AI on Nov 12, 2026.
Comments
Sign in to join the discussion.